208 results on '"Targowska-Duda, Katarzyna M."'
Search Results
2. Discovery of novel arylpiperazine-based DA/5-HT modulators as potential antipsychotic agents – Design, synthesis, structural studies and pharmacological profiling
3. Funnel metadynamics and behavioral studies reveal complex effect of D2AAK1 ligand on anxiety-like processes
4. Type I and type II positive allosteric modulators of α7 nicotinic acetylcholine receptors induce antidepressant-like activity in mice by a mechanism involving receptor potentiation but not neurotransmitter reuptake inhibition. Correlation with mTOR intracellular pathway activation
5. N-(3-{4-[3-(trifluoromethyl)phenyl]piperazin-1-yl}propyl)-1H-indazole-3-carboxamide (D2AAK3) as a potential antipsychotic: In vitro, in silico and in vivo evaluation of a multi-target ligand
6. NOP receptor agonist attenuates nitroglycerin-induced migraine-like symptoms in mice
7. Angiotensin II type 1 receptor blockers decrease kynurenic acid production in rat kidney in vitro
8. Functional and anatomical analyses of active spinal circuits in a mouse model of chronic pain
9. Functional and anatomical analyses of active spinal circuits in a mouse model of chronic pain.
10. Effect of Gemfibrozil on Kynurenine Aminotransferases Activity and Kynurenic Acid Production in Rat Kidney: PUB226
11. Influence of Cyclooxygenase-2 Inhibitors on Kynurenic Acid Production in Rat Brain in Vitro
12. Novel multi-target ligands of dopamine and serotonin receptors for the treatment of schizophrenia based on indazole and piperazine scaffolds–synthesis, biological activity, and structural evaluation
13. Positive allosteric modulators of α7 nicotinic acetylcholine receptors affect neither the function of other ligand- and voltage-gated ion channels and acetylcholinesterase, nor β-amyloid content
14. In vitro, molecular modeling and behavioral studies of 3-{[4-(5-methoxy-1H-indol-3-yl)-1,2,3,6-tetrahydropyridin-1-yl]methyl}-1,2-dihydroquinolin-2-one (D2AAK1) as a potential antipsychotic
15. The positive allosteric modulator of α7 nicotinic acetylcholine receptors, 3-furan-2-yl-N-p-tolyl-acrylamide, enhances memory processes and stimulates ERK1/2 phosphorylation in mice
16. Chapter 17 - Computational methods for studying G protein-coupled receptors (GPCRs)
17. Coronaridine congeners inhibit human α3β4 nicotinic acetylcholine receptors by interacting with luminal and non-luminal sites
18. The antidepressant-like activity of nicotine, but not of 3-furan-2-yl-N-p-tolyl-acrylamide, is regulated by the nicotinic receptor β4 subunit
19. Angiotensin II Type 1 Receptor Blockers Inhibit KAT II Activity in the Brain—Its Possible Clinical Applications
20. Efficacy of Dabrafenib and Trametinib in a Patient with Squamous-Cell Carcinoma, with Mutation p.D594G in BRAF and p.R461* in NF1 Genes—A Case Report with Literature Review
21. Synthesis, in vitro and in vivo studies, and molecular modeling of N-alkylated dextromethorphan derivatives as non-competitive inhibitors of α3β4 nicotinic acetylcholine receptor
22. Bupropion-induced inhibition of α7 nicotinic acetylcholine receptors expressed in heterologous cells and neurons from dorsal raphe nucleus and hippocampus
23. Structural and functional interaction of (±)-2-(N-tert-butylamino)-3′-iodo-4′-azidopropiophenone, a photoreactive bupropion derivative, with nicotinic acetylcholine receptors
24. Comparative molecular field analysis and molecular dynamics studies of α/β hydrolase domain containing 6 (ABHD6) inhibitors
25. Multitarget Derivatives of D2AAK1 as Potential Antipsychotics: The Effect of Substitution in the Indole Moiety
26. Structure–activity relationship of ibogaine analogs interacting with nicotinic acetylcholine receptors in different conformational states
27. WaterMap‐Guided Structure‐Based Virtual Screening for Acetylcholinesterase Inhibitors
28. Computational methods for studying G protein-coupled receptors (GPCRs)
29. Interaction of 18-methoxycoronaridine with nicotinic acetylcholine receptors in different conformational states
30. Interaction of ibogaine with human α3β4-nicotinic acetylcholine receptors in different conformational states
31. Tricyclic antidepressants and mecamylamine bind to different sites in the human α4β2 nicotinic receptor ion channel
32. Catharanthine alkaloids are noncompetitive antagonists of muscle-type nicotinic acetylcholine receptors
33. 6-Gingerol, a Major Constituent of Zingiber officinale Rhizoma, Exerts Anticonvulsant Activity in the Pentylenetetrazole-Induced Seizure Model in Larval Zebrafish
34. Is the Antidepressant Activity of Selective Serotonin Reuptake Inhibitors Mediated by Nicotinic Acetylcholine Receptors?
35. N-(2-Hydroxyphenyl)-1-[3-(2-oxo-2,3-dihydro-1H- benzimidazol-1-yl)propyl]piperidine-4-Carboxamide (D2AAK4), a Multi-Target Ligand of Aminergic GPCRs, as a Potential Antipsychotic
36. Different interaction between tricyclic antidepressants and mecamylamine with the human α3β4 nicotinic acetylcholine receptor ion channel
37. N-(2-Hydroxyphenyl)-1-[3-(2-oxo-2,3-dihydro-1Hbenzimidazol-1-yl)propyl]piperidine-4-Carboxamide (D2AAK4), a Multi-Target Ligand of Aminergic GPCRs, as a Potential Antipsychotic
38. In Vitro and In Vivo Models for the Investigation of Potential Drugs Against Schizophrenia
39. FP026DICLOFENAC INHIBITS KYNURENINE AMINOTRANSFERASE ACTIVITY AND KYNURENIC ACID PRODUCTION IN RAT KIDNEY
40. 3-Furan-2-yl-N-p-tolyl-acrylamide, a highly selective positive allosteric modulator of α7 nicotinic receptors, produces anxiolytic-like activity in mice
41. Corrigendum to “In vitro, molecular modeling and behavioral studies of '3-{[4-(5-methoxy-1H-indol-3-yl)-1,2,3,6-tetrahydropyridin-1-yl]methyl}-1,2-dihydroquinolin-2-one (D2AAK1) as a potential antipsychotic” [Neurochem. Int. 96 (2016) 84–99]
42. Angiotensin II type 1 receptor blockers decrease kynurenic acid production in rat kidney in vitro
43. Influence of Cyclooxygenase-2 Inhibitors on Kynurenic Acid Production in Rat Brain in Vitro
44. Molecular interactions of type I and type II positive allosteric modulators with the human α7 nicotinic acetylcholine receptor: an in silico study
45. Interaction of selective serotonin reuptake inhibitors with neuronal nicotinic acetylcholine receptors
46. Interaction of bupropion with muscle-type nicotinic acetylcholine receptors in different conformational states
47. In Vitro and In Vivo Models for the Investigation of Potential Drugs Against Schizophrenia.
48. Molecular interactions of type I and type II positive allosteric modulators with the human α7 nicotinic acetylcholine receptor: an in silico study.
49. Antidepressant activity in mice elicited by 3-furan-2-yl-N-p-tolyl-acrylamide, a positive allosteric modulator of the α7 nicotinic acetylcholine receptor
50. The Antinociceptive And Antiinflammatory Properties Of 3-Furan-2-Yl-N-P-Tolyl-Acrylamide, A Positive Allosteric Modulator Of Alpha 7 Nicotinic Acetylcholine Receptors In Mice
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.